Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

7.00
-0.3900-5.28%
Post-market: 7.030.0300+0.43%18:33 EDT
Volume:1.79M
Turnover:12.81M
Market Cap:1.12B
PE:-6.09
High:7.56
Open:7.47
Low:6.96
Close:7.39
Loading ...
Jun 17, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 22, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 09, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 09, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments